author-photo

Alla Volgina

Incyte

9

Papers

59

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (1)
820 MCLA-145 is a bispecific IgG1 antibody that inhibits PD-1/PD-L1 signaling while simultaneously activating CD137 signaling on T cells

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination Strategies

2019 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (31)
Abstract 3929: The FAD-directed LSD1 specific inhibitor, INCB059872, inhibits cell migration and metastasis by suppressing premetastatic niche formation in a spontaneous metastasis mouse model

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (4)
Abstract 5071: Preclinical characterization of the potent and selective BET inhibitor INCB057643 in models of hematologic malignancies

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (7)
Abstract 531: Activity of the selective FGFR 1, 2 and 3 inhibitor INCB054828 in genetically-defined models of triple-negative breast cancer

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract 3523: Discovery of a novel BET inhibitor INCB054329

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (11)